First, Salubrinal downregulates the expression and activity of Matrix Metallopeptidase 13 (MMP13), in chondrocytes, suggesting its potential use for protecting chondrocytes and treating degenerative diseases, such as osteoarthritis [6]. The gene discussed is MMP13; the disease is neurodegenerative disease.